- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07298070
Functional and Aesthetic Outcomes Following Lower Lip Reconstruction (REFEPLI)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Most lip tissue loss is secondary to cancer resection, but other causes may be responsible for this loss, whether in the upper or lower lip: trauma, infectious diseases, giant congenital nevi, hemangiomas, or clefts (labial or cleft palate).
Although the overall 5-year survival rate for skin cancers of the lip is 95%, the long-term quality of life of patients remains a major issue. The lip is both a functional and aesthetic unit, essential for speech, articulation, lip competence, eating, and facial expression.
Reconstructing extensive loss of substance in the upper and lower lips remains a surgical challenge due to the complexity of the perioral musculature and soft tissues. Despite significant advances in free transfers, locoregional flaps remain important in subtotal lip reconstruction, offering better tissue and color adaptation, partial preservation of muscle dynamics, and reduced surgical morbidity.
Reconstruction techniques vary depending on the extent of tissue loss. For defects affecting approximately half of the lip, Abbe or Estlander cross flaps using similar tissue allow functional reinnervation within 6 to 12 months. However, use of these techniques is limited by the risk of microstomia. For more extensive tissue loss (exceeding 50% of the lip), advancement or rotation flaps, such as Gilles, Bernard-Webster, or Karapandzic flaps, are preferred. Finally, tissue loss exceeding 80% or extending beyond the labio-mental sulcus or toward the cheek often requires free tissue transfer, with the risk of impaired lip function and a less than optimal aesthetic result.
Historically, the gold standard technique for lower lip reconstruction is that described by Camille Bernard in 1853, modified by Webster in 1960. Although traditionally considered adynamic due to the sectioning of the perioral muscles, clinical experience suggests that preserving the modiolus and its muscular attachments allows for the maintenance of some tone and mobility in the long term. This structure, the point of convergence of the superficial and deep fascias, plays a key role in lip dynamics by connecting the elevators, depressors, and lateral retractors.
A few studies describe facial reconstruction techniques, with the reference for the lower lip being that described by Camille Bernard in 1853, reviewed by Webster in 1960, but few if any of them focus on the functional and aesthetic results after reconstruction. For example, the retrospective analysis conducted by J. Faulhaber's team reports patient satisfaction in terms of aesthetics and function at the usual follow-up appointment, without substantiating the reasons for this alleged satisfaction. In the study conducted by E. E. Ünsal Tuna et al, a questionnaire was developed to collect functional and aesthetic outcomes from patients, but it was completed by healthcare professionals during a follow-up appointment. The same is true in the prospective study conducted by R. Denadai et al, where although patients are asked about their overall satisfaction with the functional aspect of the reconstruction, it is nevertheless healthcare professionals who more accurately assess the functional results after the reconstruction.
This study therefore focuses on analyzing the post-operative experience of patients, as well as gathering the analysis of doctors and surgeons working on facial issues (plastic surgeons and dermatologists). The aim of the study is to optimize future therapeutic strategies by providing factual information to help decide between the various therapeutic options. It is important to ensure optimal patient care, guaranteeing aesthetic and functional satisfaction, combined with an acceptable quality of life.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Maryline Delattre
- Phone Number: 0033130754131
- Email: maryline.delattre@ght-novo.fr
Study Contact Backup
- Name: Véronique Da Costa
- Phone Number: 0033130755069
- Email: veronique.dacosta@ght-novo.fr
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patient over 18 years of age.
- Patients who underwent lower lip reconstruction after excision for skin carcinoma, operated on in Pontoise between January 1, 2014, and October 31, 2025.
- Patients who had a post-operative follow-up consultation (± 2 months).
- Patients who were informed and did not object to participating in the study
Exclusion Criteria:
- Cognitive impairment preventing completion of the questionnaire.
- Patient under legal protection (guardianship, conservatorship, or judicial protection).
- Patient deceased.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall patient satisfaction with the functional and aesthetic outcomes of lip reconstruction at 12 months postoperatively, assessed by a self-reported questionnaire.
Time Frame: 12 months postoperatively (data collected upon return of completed questionnaire)
|
On the questionnaire, the patient is asked to rate from 1 to 10, where 1 means "strongly disagree" and 10 means "strongly agree."
|
12 months postoperatively (data collected upon return of completed questionnaire)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Correlation between overall patient satisfaction and various functional and aesthetic aspects of the face and their impact on daily life.
Time Frame: 12 months postoperatively (data collected upon return of completed questionnaire)
|
On the questionnaire, at the end of each subsection, the patient is asked to rate from 1 to 10, where 1 means "strongly disagree" and 10 means "strongly agree."
|
12 months postoperatively (data collected upon return of completed questionnaire)
|
|
Postoperative complications up to one year after surgery
Time Frame: Postoperative period from day 0 to one year
|
Postoperative complications lasting up to one year, including nonunion, the need for revision surgery, and in particular commissuroplasty.
|
Postoperative period from day 0 to one year
|
|
Quality of life one year after surgery
Time Frame: 12 months postoperatively (data collected upon return of completed questionnaire)
|
Quality of Life Questionnaire: University of Washington Quality of Life Questionnaire
|
12 months postoperatively (data collected upon return of completed questionnaire)
|
|
Compare patients' aesthetic perceptions with those of professionals
Time Frame: 12 months postoperatively (data collected upon return of completed questionnaire)
|
Correlation between aesthetic satisfaction perceived by patients and the one assessed by professionals, using a patient-reported outcome questionnaire and another questionnaire for professionals to evaluate the aesthetic appearance after reconstruction
|
12 months postoperatively (data collected upon return of completed questionnaire)
|
|
Demonstrate a correlation between the aesthetic success of the procedure and the technical complexity of its execution.
Time Frame: 12 months postoperatively (data collected upon return of completed questionnaire)
|
Evaluation of aesthetic results and technical complexity of procedures based on the technique used, using a questionnaire intended for physicians and surgeons working on topics related to the face
|
12 months postoperatively (data collected upon return of completed questionnaire)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: AL TABAA AL TABAA, Dr, Hôpital NOVO - Site PONTOISE
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHRD1425
- 2025-A01933-46 (Other Identifier: ANSM)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Palleon Pharmaceuticals, Inc.CompletedMelanoma | Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | NSCLC | Non Small Cell Lung Cancer | Bladder Cancer | Colon Cancer | Urothelial Cancer | Oncology | CRC | Esophagogastric Junction Cancer | EGJUnited States
-
University of California, San DiegoWithdrawnCervical Cancer | Cervical Cancer Stage | Cervical Cancer Stage IB2 | Cervical Cancer Stage IB1 | Cervical Cancer Stage I | Cervical Cancer Stage IB | Cervical Cancer Stage II | Cervical Cancer Stage IIa | Cervical Cancer, Stage IIB | Cervical Cancer, Stage III | Cervical Cancer Stage IIIB | Cervical Cancer... and other conditionsUnited States
-
Morehouse School of MedicineRecruiting
Clinical Trials on Patient-Reported Outcome Questionnaire (post-operative)
-
Seoul National University HospitalSK Telecom ConsortiumCompleted
-
University Hospital, Clermont-FerrandCompletedPain | Cancer | Substance UseFrance
-
Centre Hospitalier Universitaire de NīmesCompleted
-
University Hospital HeidelbergHealth Economics and Health Care Management, Bielefeld University; Chair of... and other collaboratorsCompleted
-
Centre Hospitalier National d'Ophtalmologie des...Not yet recruitingAge-Related Macular Degeneration
-
Fondation Hôpital Saint-JosephRecruiting
-
University Hospital, Basel, SwitzerlandWithdrawnAvascular Necrosis of the Femoral Head
-
Geisinger ClinicPatient-Centered Outcomes Research Institute; Penn State University; University... and other collaboratorsCompletedPediatric Obesity | Preventive Medicine | Mentoring | Food SupplyUnited States
-
Radboud University Medical CenterJeroen Bosch ZiekenhuisRecruitingPatient Engagement | Intensive Care Unit SyndromeNetherlands
-
Karolinska InstitutetSkandinaviska Forskningsstiftelsen för Åderbråck och andra VensjukdomarCompletedQuality of Life | Superficial Venous Insufficiency | Change After TreatmentSweden